The Founders
Five operators who collectively control the clinics, the practitioners, the manufacturing, the clinical validation, and the hardware. No critical dependency is outsourced.
Byung Kim
Co-Founder & CEO
Built Virginia University of Integrative Medicine (VUIM) into one of the largest integrative medicine training pipelines in the US. 15+ years operating experience across clinical ecosystems. 1,000+ alumni practitioners treating millions of patient visits. Owns B2B2C distribution, clinical operations, and practitioner partnerships.
Will Yeung
Co-Founder & CTO
Systems engineer and AI technologist. 15 years building technical infrastructure in regulated environments. Led delivery and strategy across $300M in booked AI engagements and a $2B pipeline. Built 18+ AI applications deployed across major US federal departments. Owns full technical stack, AI personalization, and retention infrastructure.
Sung Koo
Co-Founder & VP of Supplement Technologies
Leads Okchundang, a scaled Korean herbal medicine manufacturer with ~25.5B KRW annual revenue. 20+ patents in herbal formulation. 3.1 million+ prescriptions fulfilled since 2014. Owns formulation integrity, exclusive manufacturing rights, and production scalability for NanoActives.
Dr. Lixing Lao
VP of Clinical Research
President and Professor at VUIM. Globally recognized leader in integrative medicine research. 370+ published works, 18,500+ citations. Defines validation protocols, practitioner-acceptable outcomes, and clinical guardrails.
Spring Xu
VP of Wearable Technologies
Nearly 20 years of experience across finance, technology, and global trade. Nine years in banking. Achieved 22% COGS reduction on Mere Pulse with FCC and CE prescan progress. Owns wearable execution across cost, quality, and certification.
Every Critical Layer. Owned Internally.
Mere does not license its formulations, outsource its hardware, or depend on third-party clinical networks. Each founder controls a layer of the stack that competitors would need years to replicate.
Distribution
1,000+ practitioner alumni across 20+ states. B2B2C channel built over 15 years.
Manufacturing
3.1M+ prescriptions fulfilled. 20+ patents. Exclusive rights to patented nano-microbead formulation.
Clinical Validation
370+ published works. 18,500+ citations. Protocols designed for practitioner-acceptable outcomes.
Hardware
22% COGS reduction achieved. FCC and CE prescan in progress. Full wearable supply chain ownership.
Technology
18+ AI applications in production. $300M in booked AI engagements. Full-stack AI personalization.